Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: A 2015 position statement of the Italian Society of Endocrinology

F. Pacini, E. Brianzoni, C. Durante, R. Elisei, M. Ferdeghini, L. Fugazzola, S. Mariotti, G. Pellegriti

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid cancer (DTC) is aimed to destroy any thyroid remnant in the thyroid bed (remnant ablation) and any microscopic foci of cancer cells eventually present within the thyroid remnant (adjuvant therapy). The present text is an attempt to offer practice guidelines for the indication of thyroid ablation and the preparation of DTC patients considering the latest achievement in the field and the changing epidemiology of DTC observed in the last 10 years. Methodology: The executive committee of the Italian Society of Endocrinology appointed a task force of thyroid cancer expert including Nuclear Medicine Physicians and Endocrinologists to provide a consensus on the post-surgical ablation in thyroid cancer patients. The task force had no conflict of interest and had no commercial support. A number of specific topics were selected and the members selected relevant papers by searching in the Pubmed for articles published from 2000 to January 2015. Selected studies were categorized by level of evidence, and the recommendations were graded according to the level of evidence as high (A), moderate (B), or low (C).

Original languageEnglish
Pages (from-to)341-347
Number of pages7
JournalJournal of Endocrinological Investigation
Volume39
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Endocrinology
Thyroid Neoplasms
Thyroid Gland
Advisory Committees
Conflict of Interest
Nuclear Medicine
Practice Guidelines
PubMed
Iodine
Consensus
Epidemiology
Physicians
Neoplasms

Keywords

  • Radioiodine
  • rhTSH
  • Thyroglobulin
  • Thyroid ablation
  • Thyroid cancer

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer : A 2015 position statement of the Italian Society of Endocrinology. / Pacini, F.; Brianzoni, E.; Durante, C.; Elisei, R.; Ferdeghini, M.; Fugazzola, L.; Mariotti, S.; Pellegriti, G.

In: Journal of Endocrinological Investigation, Vol. 39, No. 3, 01.03.2016, p. 341-347.

Research output: Contribution to journalArticle

Pacini, F. ; Brianzoni, E. ; Durante, C. ; Elisei, R. ; Ferdeghini, M. ; Fugazzola, L. ; Mariotti, S. ; Pellegriti, G. / Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer : A 2015 position statement of the Italian Society of Endocrinology. In: Journal of Endocrinological Investigation. 2016 ; Vol. 39, No. 3. pp. 341-347.
@article{9c4801e09d9d4e088ce2d86757137f39,
title = "Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: A 2015 position statement of the Italian Society of Endocrinology",
abstract = "Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid cancer (DTC) is aimed to destroy any thyroid remnant in the thyroid bed (remnant ablation) and any microscopic foci of cancer cells eventually present within the thyroid remnant (adjuvant therapy). The present text is an attempt to offer practice guidelines for the indication of thyroid ablation and the preparation of DTC patients considering the latest achievement in the field and the changing epidemiology of DTC observed in the last 10 years. Methodology: The executive committee of the Italian Society of Endocrinology appointed a task force of thyroid cancer expert including Nuclear Medicine Physicians and Endocrinologists to provide a consensus on the post-surgical ablation in thyroid cancer patients. The task force had no conflict of interest and had no commercial support. A number of specific topics were selected and the members selected relevant papers by searching in the Pubmed for articles published from 2000 to January 2015. Selected studies were categorized by level of evidence, and the recommendations were graded according to the level of evidence as high (A), moderate (B), or low (C).",
keywords = "Radioiodine, rhTSH, Thyroglobulin, Thyroid ablation, Thyroid cancer",
author = "F. Pacini and E. Brianzoni and C. Durante and R. Elisei and M. Ferdeghini and L. Fugazzola and S. Mariotti and G. Pellegriti",
year = "2016",
month = "3",
day = "1",
doi = "10.1007/s40618-015-0375-7",
language = "English",
volume = "39",
pages = "341--347",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "3",

}

TY - JOUR

T1 - Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer

T2 - A 2015 position statement of the Italian Society of Endocrinology

AU - Pacini, F.

AU - Brianzoni, E.

AU - Durante, C.

AU - Elisei, R.

AU - Ferdeghini, M.

AU - Fugazzola, L.

AU - Mariotti, S.

AU - Pellegriti, G.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid cancer (DTC) is aimed to destroy any thyroid remnant in the thyroid bed (remnant ablation) and any microscopic foci of cancer cells eventually present within the thyroid remnant (adjuvant therapy). The present text is an attempt to offer practice guidelines for the indication of thyroid ablation and the preparation of DTC patients considering the latest achievement in the field and the changing epidemiology of DTC observed in the last 10 years. Methodology: The executive committee of the Italian Society of Endocrinology appointed a task force of thyroid cancer expert including Nuclear Medicine Physicians and Endocrinologists to provide a consensus on the post-surgical ablation in thyroid cancer patients. The task force had no conflict of interest and had no commercial support. A number of specific topics were selected and the members selected relevant papers by searching in the Pubmed for articles published from 2000 to January 2015. Selected studies were categorized by level of evidence, and the recommendations were graded according to the level of evidence as high (A), moderate (B), or low (C).

AB - Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid cancer (DTC) is aimed to destroy any thyroid remnant in the thyroid bed (remnant ablation) and any microscopic foci of cancer cells eventually present within the thyroid remnant (adjuvant therapy). The present text is an attempt to offer practice guidelines for the indication of thyroid ablation and the preparation of DTC patients considering the latest achievement in the field and the changing epidemiology of DTC observed in the last 10 years. Methodology: The executive committee of the Italian Society of Endocrinology appointed a task force of thyroid cancer expert including Nuclear Medicine Physicians and Endocrinologists to provide a consensus on the post-surgical ablation in thyroid cancer patients. The task force had no conflict of interest and had no commercial support. A number of specific topics were selected and the members selected relevant papers by searching in the Pubmed for articles published from 2000 to January 2015. Selected studies were categorized by level of evidence, and the recommendations were graded according to the level of evidence as high (A), moderate (B), or low (C).

KW - Radioiodine

KW - rhTSH

KW - Thyroglobulin

KW - Thyroid ablation

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=84959047070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959047070&partnerID=8YFLogxK

U2 - 10.1007/s40618-015-0375-7

DO - 10.1007/s40618-015-0375-7

M3 - Article

AN - SCOPUS:84959047070

VL - 39

SP - 341

EP - 347

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 3

ER -